Advancing Diabetes Management in Adolescents Using Health Information Technology

February 18, 2019 updated by: Tamara S. Hannon, Indiana University

The study will compare three treatment strategies to look at the best clinical outcomes.

The investigator hypothesizes that the combined approach of a health information technology program plus a conflict-management contract will lead to the best outcomes.

Study Overview

Detailed Description

This study will compare three strategies for enhancing adherence to diabetes care in our population. The study will look at which strategy results in the best short-term clinical outcomes for the population. Also, the study will look at patient satisfaction of contact with his/her health care team, quality of life, and family dynamics.

The three arms are:

  1. HIT (health information technology) aided approach
  2. Contracted conflict-management strategy
  3. Combination of the HIT-aided approach and the contracted conflict management strategy

Study Type

Interventional

Enrollment (Actual)

129

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Carmel, Indiana, United States, 46032
        • Riley Children's Specialties
      • Indianapolis, Indiana, United States, 46202
        • Riley Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Type 1 diabetes diagnosed for at least 6 months
  • At least one or more parent/guardian who agrees to participate

Exclusion Criteria:

  • Other chronic diseases with the exception of well-controlled asthma or treated thyroid disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HIT-aided approach
Adolescents and their parents randomized to this arm will be oriented on a HIT system. The system transmits self monitoring blood glucose self monitoring blood glucose data to a secure web portal. The subject will receive messages from the HIT system on the meter based upon the Self Monitored Blood glucose tests.
Subjects randomized to this approach will be using the HIT-aided monitor.
Experimental: Contracted conflict management system
Adolescent-parent pairs will meet with a health educator to establish a behavioral contract that will set patient-centered self-management goals for the adolescent.
Subjects randomized to this arm will be using the behavioral contracted conflict management system.
Experimental: HIT plus contracted conflict management
Adolescents and their parents randomized to this arm will be oriented on a HIT system. The system transmits self monitoring blood glucose data to a secure web portal. The subject will receive messages from the HIT system on the meter based upon the tests. In addition, adolescent-parent pairs will meet with a health educator to establish a behavioral contract that will set patient-centered self-management goals for the adolescent. This arm combines arms 1 and 2.
Subjects randomized to this arm will use both the HIT-aided approach and the behavioral contract conflict management system.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic Control using HBA1C
Time Frame: Baseline, 3 months, and 6 months
Change in Glycemic Control
Baseline, 3 months, and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of self monitoring blood glucose measurement
Time Frame: Baseline, 3 months, 6 months
change in Self-monitoring blood glucose measurement
Baseline, 3 months, 6 months
Quality of Life
Time Frame: Baseline and 6 months
Change in Diabetes-specific quality of life measures will be measured by the Varney's Pediatric Quality of Life 3.0 Diabetes Module.
Baseline and 6 months
Family dynamics
Time Frame: Baseline and 6 months
Change in family dynamics measured by the Cornell Parent Behavior Description Scale and the Helping for Health Inventory.
Baseline and 6 months
Treatment Adherence Behaviors
Time Frame: Once per month for 6 months
Change in treatment adherence behaviors measured by the Self-Care Inventory with supplemental questions determined by the investigator.
Once per month for 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction
Time Frame: 3 month and 6 month
Patient and parent satisfaction with the intervention with questions determined by the investigator.
3 month and 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tamara Hannon, MD, Indiana University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2014

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

March 17, 2014

First Submitted That Met QC Criteria

April 14, 2014

First Posted (Estimate)

April 16, 2014

Study Record Updates

Last Update Posted (Actual)

February 20, 2019

Last Update Submitted That Met QC Criteria

February 18, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will be shared via presentation and publications.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 1 Diabetes

Clinical Trials on HIT-aided approach

3
Subscribe